Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLC
Clinical trial NCT02954172 · COMPLETED
Trial details
- NCT number
- NCT02954172
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-28
- Primary completion
- 2018-10-19
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.